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Abstract
The hypocretin peptides are two hypothalamic peptides known to be involved in both
sleeping and feeding behavior, however their specific roles in these domains are not well
understood. The present study sought to determine the effect of chronic (72-hour) sleep
deprivation and (48-hour) food deprivation on preprohypocretin (PPH), which is the precursor
for the hypocretin peptides. PPH levels were visualized and quantified via in situ hybridization.
A three-factor ANOVA ( group x dorsal/ventral x medial/lateral) revealed a significant effect of
subregion, specifically dorsal/middle and ventral/medial exhibited elevated PPH levels, however
there was no effect of group. A between group one-way ANOVA revealed no effect of group on
PPH levels. It is theorized that four possible domains may be responsible for these results:
presence of hypothalamic neuronal subpopulations, role of circadian rhythm, role of hypocretins
in locomotive behavior and inextricably confounded variables. These are discussed at length.
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Introduction
A silent epidemic of sleep deprivation has grown among American citizens. A study
recently released by the National Sleep Foundation states that 51% of American adults report
sleepiness on the job to be interfering with optimal job performance; these adults further estimate
that the quality and quantity of their work is regularly diminished by about 30% (National Sleep
Foundation Omnibus Poll, 2000). This phenomenon is not limited to adults; 33% of young
adults also report chronic daytime sleepiness. Despite this probably the most staggering finding
is that over 100,000 automobile accidents are annually attributed to sleep deprivation.
Many empirical investigations have demonstrated that sleep deprivation can result in
significant cognitive impairments. For example, one night’s loss of sleep resulted in impairments
in an auditory task and a logical reasoning task (Blagrove, Alexander, & Horne, 1995), and 3436 hours of sleep deprivation resulted in impairments on a word fluency test as well as an
impairment in the ability to attend to relevant environmental stimuli or exhibit optimal response
to stimuli (Harrison & Horne, 1997). Researchers also reported a tendency for subjects to lose
interest in stimuli more rapidly following a 34-36 hour sleep deprivation period versus controls,
in addition to generally exhibiting slower and more variable processing of the stimuli (McCarthy
& Waters, 1997). Several investigators have suggested this decrement in function may result
from an increased prefrontal cortex workload that arises in an attempt to combat sleep loss
(Drummond & Brown, 2001a; Kim, Guilleminault, Hong, Kim, Kim, Go, et al., 2001;
Drummond, Gillin & Brown, 2001b).
One prominent study put the effects of sleep loss into perspective by comparing the
effects of total sleep deprivation and alcohol consumption on hand-eye coordination. Subjects
were divided into two groups; the first group of subjects were kept awake for a period of up to 28
hours and the second group of subjects were asked to consume 10-15g of alcohol every 30
minutes until their blood alcohol level reached 0.10% (note that current federal regulations
stipulate a blood alcohol level of 0.08% to constitute legal intoxication). These researchers
found that 17 hours of sustained wakefulness diminished hand-eye coordination to a level
comparable to a 0.05% blood alcohol level and that a 24-hour extended wakefulness period
produced deficits comparable to a 0.10% blood alcohol level (Dawson & Reid, 1997).
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Finally, a meta-analysis revealed that cognitive performance and mood were significantly
impaired following short and long term sleep deprivation periods (from 1 to 45+ hours of sleep
loss) and that persistent partial sleep deprivation (less then 5 hours of sleep in a 24 hour period)
resulted in higher cognitive and mood impairments than either the short or long term sleep
deprivation (Pilcher & Huffcutt, 1996). This latter finding is most alarming as it most closely
mimics the sleep deprivation experienced by a large part of today’s societal members (National
Sleep Foundation Omnibus Poll, 2000).
The cognitive deficiencies found in humans are also prominent in animal models of sleep
deprivation (for review, see Siegel, 2001). Work from our laboratory, for example, has found a
72-hour sleep deprivation period (accomplished via the platform over water method) to be
sufficient for producing impairments in a hippocampally-mediated spatial memory version of the
Morris Water Maze task in adult rats (Billiot, Gordon, Bazan, & LaHoste, G.J. 2002). Further
evidence suggests that the hippocampus may be particularly vulnerable to the disruptive effects
of sleep deprivation. In rats deprived of sleep for 72-hours hippocampally-mediated contextual
memory (as measured in a fear conditioning task) was impaired, whereas amygdala-mediated
cued memory remained intact in the same animals (McDermott, LaHoste, Chen, Musto, Bazan &
Magee, 2003; Ruskin, Liu, Dunn, Bazan & LaHoste, 2004). Hippocampal dysfunction as the
neuroanatomical substrate for these behavioral deficits is further supported by in vitro and in vivo
electrophysiological studies. Hippocampal long-term potentiation (LTP) was found to be
diminished in hippocampal slices from rats deprived of sleep for 12 (Cambell, Guinan &
Horowitz, 2002) or 72 hours (McDermott et al., 2003). Identical findings were obtained using in
vivo recordings from anesthetized rats deprived of sleep for 72 hours (Billiot et al., 2002). These
findings indicate that sleep deprivation disrupts the neural physiological mechanisms thought to
be involved in memory processes.
The aforementioned information indicates that diminished cognitive performance due to
sleep deprivation is a prominent epidemic in our society. However little is known about the
neuronal consequences of sleep deprivation. The successful modeling of sleep deprivationinduced cognitive deficits in rodents opens the door to studies aimed at elucidating these
neuronal consequences, thereby leading to the potential development of performance-preserving
strategies.
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Classical Sleep Pathways
In order to successfully combat the detrimental effects of sleep loss, or abnormal sleep
conditions, it is important first to understand the mechanisms behind sleep. To date it has
become clear mammalian brains have two opposing processes, namely the induction of arousal
and the induction of sleep. The neural pathways of these two processes are independent from
each other. The arousal pathway (often referred to as the ascending reticular activating system)
is comprised of both a dorsal and ventral pathway. Both of these pathways originate in the
pontomesencephalic brain stem. While the dorsal pathway travels through the thalamus and
eventually finalizes into diffuse cortical dispersions, the ventral pathway passes through the
hippocampus and the basal forebrain prior to branching into cortical projections (Siegel, 2002, p.
49).
The pathways responsible for sleep are also divided into two types, one for rapid eye
movement (REM) sleep (also called ‘paradoxical sleep’ because of the awake-like pattern of
cortical EEG) and one for non-REM sleep. Non-REM sleep, better known as slow wave sleep,
results from a negative feedback system between the reticular nucleus of the thalamus and the
cortex, while the major brain area associated with REM sleep is located in the mid to caudal pons
area (Siegel, 2002, p117).
Hypocretins
It was not until recently that a new mechanism contributing to the sleep-wake pattern was
discovered. Nearly simultaneously two independent groups of researchers announced the
discovery of a pair of novel neuropeptides highly concentrated in the hypothalamus of rats.
Termed either hypocretin 1 and 2 (de Lecea, Kilduff, Peyron, Gao, Foye, Danielson, et al.,
1998) or orexin A and B (Sakurai, Amemiya, Ishii, Matsuzaki, Chemelli, Tanaka, et al., 1998),
these neuropeptides are synthesized from a 130-amino acid precursor peptide known as preprohypocretin (PPH) or prepro-orexin, respectively (Sakurai et al., 1998). (The nomenclature of de
Lecea et al. will be followed for the remainder of this paper.)
Hypocretin 1 and 2 consist of 33- and 28-amino acid residues, respectively (Sakurai et
al., 1998). They can be found in dense-core vesicles at presynaptic axon terminals (de Lecea et
al., 1998), and their interaction with specific receptors initiates postsynaptic intracellular
signaling cascades (Ca2+ mobilization; (Holmqvist, Akerman, & Kukkonen, 2002), suggesting
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that the hypocretins act as releasable neuropeptide neurotransmitters. Since the discovery of
hypocretins in rats these peptides have subsequently been detected in humans, mice, pigs, cows,
amphibians and non-human primates (Smart & Jerman, 2002). The amino acid sequence of
hypocretin 1 is identical in all species examined, whereas that of hypocretin 2, although highly
conserved, differs somewhat across species.
The hypocretins bind to two different G-protein coupled receptors, identified as
hypocretin receptor 1 (Hypocretin-R1) and hypocretin receptor 2 (Hypocretin-R2).
Investigations have linked Hctr-1 with Gq proteins while Hypocretin-2 has been linked with both
Gq and Gi proteins (Mieda & Yanagisawa, 2002; Shiba, Ozu, Yoshida, Mignot, & Nishino,
2002). Hypocretin 1 and 2 both bind to Hypocretin-R2 with equal affinity. However, hypocretin
1 binds to Hypocretin-R1 with 30-100 fold higher affinity than does hypocretin 2 and its affinity
for this receptor is similarly greater than its affinity for Hypocretin-R2 (hypocretin 2 binds with
similar affinity to Hypocretin-R1 and Hypocretin-R2) (Sakurai et al., 1998). This has prompted
the belief that Hypocretin-R1 is selective for hypocretin 1 transmission (Holmqvist et al., 2002).
Neuronal cell bodies and axonal projections. Neuronal cell bodies containing
hypocretins are distributed exclusively within the tuberal region of the dorsal hypothalamus,
extending 1 mm rostrocaudally beginning posterior to the paraventricular nucleus, ~1.5 mm
mediolaterally beginning at the third ventricle, and slightly less than 1 mm ventral from the
dorsal peak of the third ventricle (Peyron, Tighe, van den Pol, de Lecea, Helle, Sutcliff, et al.
1998). The hypocretin-positive cells form a roughly continuous mediolateral cluster across the
dorsomedial nucleus of the hypothalamus, the perifornical region, and the lateral hypothalamic
area, the perifornical region itself containing approximately 50% of the hypocretin neurons. The
observed distribution is identical regardless of whether the cell bodies are visualized using
immunocytochemistry with antibodies against the hypocretin peptides or with in situ
hybridization using RNA probes complementary to PPH (Peyron et al., 1998). As of yet,
however, there are no quantitative data on the regional expression of PPH mRNA within the
hypothalamus.
Despite the discrete localization of the cell bodies, hypocretin axons project diffusely
throughout the brain. The widespread projection pathways terminate in many brain areas
including the cerebral cortex, hippocampus, amygdala, thalamus, septum, basal ganglia, central
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gray and several raphe nuclei (Peyron et al., 1998; Nambu, Sakurai, Mizukami, Hosoya,
Yanagisawa, & Goto, 1999; Smart & Jerman, 2002; Fadel, & Deutch, 2002). The specific
locations of these connections, as well as their fiber densities, are summarized in Table 1. These
projections, illustrated schematically in Figure 1, do not differ between diurnal and nocturnal
species (Novak & Albers, 2002).

Figure 1. Schematic drawing of sagittal section through the rat brain to summarize the organization of the hypocretinergic
neuronal systems. Dots indicate the location of hypocretin-like immunoreactive neurons, lines indicate some of the more
prominent projection pathways, and arrows indicate terminal fields. [Abbreviations: 3V, third ventricle; 4V, fourth ventricle;
ARC, arcuate nucleus; DMH, dorsomedial hypothalamus; LC, locus coeruleus; LDT, lateral dorsal tegmental nucleus; PPT,
posterior pretectal nucleus; PVN, paraventricular nucleus; SCN, suprachiasmatic nucleus; TMN, tuberomamillary nucleus;
VLPO, ventrolateral preoptic area; VMH, ventromedial hypothalamus] From Mieda and Yanagisawa, 2002.
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Table 1- Hypocretin Projections: Anatomical Localization and Average Concentration
Brain Region
Cortex (Layers 1-6)
Hippocampus
Amygdala
Central Nucleus and Anterior Amygdala Area
Medial Nucleus
Basolateral, Basomedial, Cortical, Lateral and Intercalated Nuclei
Septum
Lateral and Medial Nucleus
Septofimbrial Nucleus
Diagonal band of Broca
Horizontal Limb
Vertical Limb
Bed nucleus of Stria Terminalis
Ventral, Posterolateral nuclei
Lateral, Medial, Posteromedial nuclei
Basal Ganglia
Accumbens nucleus, shell
Accumbens nucleus, core
Thalamus
Central medial; Paraventricular; Subincertal; Subthalamic; Central Gray nuclei
Rhomboid; Zona incerta, caudal; Parafasicular nuclei
Anterior Hypothalamus
Substantia innominata
Medial, Lateral preoptic area; Lateroanterior nucleus; Ventral Pallidum
Medial preoptic nucleus; anterior hypothalamic area, anterior part
Posterior Hypothalamus
Perifornical nucleus
Ventromedial; Dorsomedial; Arcuate; Submammillary; Tuberomammillary nuclei
Dorsal, Lateral, Posterior hypothalamic areas; Tuberum cinereum
Paraventricular nucleus
Midbrain
Substantia nigra, pars compacta; Central gray
Substantia nigra, lateral part; Ventral Tegmental Area; Interpenduncular Nucleus
Brain Stem
Trigeminal, Facial, Hypoglossal and Vagus motor nuclei
Somatosensory Nuclei
Nucleus of the Solitary Tract
Lateral lemniscus; Parabrachial nucleus
Superior, Inferior Colliculi; Cochlear nucleus, dorsal; Vestibular nuclei; Area postrema
Central Gray Nuclei
Locus Coeruleus
Periaqueductal gray
Barrington’s nucleus; Laterodorsal tegmental nucleus
Raphe Nuclei
Raphe dorsalis; Raphe magnus
Raphe median; B9
Raphe pallidus; Raphe obscurus; Raphe linearis; Raphe Pontis

Fiber
Density
++
+
+++
++
+
+++
++
+++
++
++++
+++
++
+
++++
++
++++
+++
++
+++++
++++
++++
+++
++++
+++
+
++++
+++
++
+++++
++++
+++
++++
+++
++

Rating Scale: +++++ - greatest fiber density, + - lowest fiber density, (Adapted from Peyron et al., 1999.)
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Table 2- Hypocretin Receptors: Anatomical Localization and Concentration
Brain Region
Cerebral Cortex
Neocortex, Layer VI
Neocortex, Layer V
Neocortex, Layer II
Cingulate cortex, Layer III
Piriform Area
Infralimbic Area
Prefrontal Cortex
Amygdala
Bed nucleus of the stria terminalis
Medial nucleus, anterolateral part
Cortical nucleus
Central nucleus
Substantia innominata
Hippocampus and Septum
Taenia tecta
Faciola cinerea
Lateral septal nucleus
Medial septal nucleus
Nucleus of the diagonal band, vertical limb
Nucleus of the diagonal band, horizontal limb
Dentate Gyrus
CA1
CA2
CA3
Thalamus
Centraolateral thalamus
Centromedial thalamus
Paraventricular nucleus thalamus
Rhomboid nucleus
Hypothalamic nuclei
Anterior hypothalamic area, anterior
Anterior hypothalamic nucleus
Arcuate nucleus hypothalamus
Dorsal hypothalamic area
Lateral Hypothalamic area
Posterior Hypothalamus
Midbrain
Dorsal raphe nucleus
Locus coerulus
Medial raphe nucleus
Periaqueductal gray matter
Substantia nigra, pars compacta
Ventral tegmental area

HypocretinR1

HypocretinR2

+
+
++
++
++

++
++
++
+
-

+++
++
+
+
+

++
+
++
+

+++
++
+
++
++
+
++
-

+
++
+
+++
++
+++
+
+++

+
+
+++
+

++
++
++
+++

++
+++
++
+
++

+
+
+++
+
+++
++

++
+++
++
++
++
++

++
+
++
++
++
++

Rating Scale: +++: Highest receptor density, +: lowest receptor density, -: negligable receptor density.
(Adapted from Marcus et al., 2001.)
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Receptors. Hypocretin-R1 and Hypocretin-R2 are expressed differentially throughout the
brain. Although both Hypocretin-R1 and Hypocretin-R2 are expressed in brain regions such as
the amygdala, the hippocampus, the thalamus, the hypothalamus and the midbrain area, the
extent to which each receptor exists in any given nuclei is variable. The specific anatomical
locations of Hypocretin-R1 and Hypocretin-R2 as well as their average density, are summarized
in Table 2. (Marcus, Aschkensali, Lee, Chemelli, Saper, Yanagisawa, et al., 2001).
Role of endogenous hypocretins in sleep and arousal. The hypothalamic location of the
hypocretinergic neurons suggests a role for Hypocretins in such in homeostatic mechanisms as
sleeping and feeding behaviors. Indeed, these two behaviors were the first examined in the
search for a functional role for the hypocretins. The role of hypocretins in sleeping behavior was
recognized with the creation of hypocretin-knockout mice (Chemelli, Willie, Sinton, Elmquist,
Richardson, Lee, et al., 1999). Disruption of the PPH gene prevented synthesis of either
hypocretin 1 or hypocretin 2. Mice that were homozygous for the knockout allele (-/-)
succumbed to numerous spontaneous periods of inactivity. Further investigation revealed these
mice to be suffering from a form of narcolepsy. Around the same time it was discovered that
narcolepsy in Doberman pinschers (a prominent dog model of human narcolepsy) resulted from
a mutation in the Hypocretin-R2 gene (Lin, Faraco, Li, Kadotani, Rogers, Lin, et al., 1999).
Human narcolepsy has since been associated with a substantial degeneration (approximately
85%-95%) of hypocretin-containing neurons, as determined post mortem (Thannickal, Moore,
Nienhuis, Ramanathan, Gulyani, Aldrich, et al., 2000). (However, human narcolepsy is not
familial and the cause of the hypocretinergic cell death is still unknown.) These serendipitous
findings, implicating a role for the hypocretins in abnormal sleeping behaviors, prompted
researchers to begin examining the role of hypocretins in normal sleeping behaviors.
Hypocretins have also been implicated in the circadian rhythm cycle. In laboratory rats,
pontine hypocretin 1 immunoreactivity have been observed to fluctuate in a circadian manner.
Hypocretin levels rise steadily just prior to the dark cycle and lower just prior to the onset of the
light cycle (Taheri, Sunter, Dakin, Moyes, Seal, Gardiner, et al., 2000). Hypothalamic PPH
mRNA also showed a steady decline towards lights out (Taheri et al., 2000). In order to rule out
the chance that fluctuations in hypocretin levels are related to photic stimuli, Martinez and
colleagues (2002) performed double immunocytochemistry staining for the immediate early gene
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Fos and hypocretin in nocturnal (Rattus norvegicus, laboratory rats) and diurnal (Arvicanthus
niloticus, Nile grass rats) rat species. Animals were sacrificed at six different time points
throughout a 24 hour period. The proportion of hypocretin-positive neurons that were also Fospositive (an indicator of neuronal activity) was reported to be most elevated at time points during
which the animals were most active, regardless of light phase (Martinez, Smale, & Nunez, 2002).
Another study that double-labeled for Fos and hypocretins also found the proportion of doublelabeled cells to be elevated in nocturnal rats during the night (active phase); additionally, animals
housed in 24-hour darkness also showed a rise in hypocretins levels during the subjective night
phase of the circadian cycle (Estabrooke, McCarthy, Ko, Chou, Chemelli, Yanagisawa, et al.,
2001).
A microdialysis study in cats revealed a positive correlation between wakefulness and
hypocretin 1 levels in the hypothalamus (Kiyashchenko, Mileykovskiy, Maidment, Lam, Wu,
John, et al., 2002). Interestingly, hypocretin 1 levels were increased in the basal forebrain and
hypothalamus during REM sleep relative to slow-wave sleep. In the locus coeruleus, a major
arousal area that receives the densest input of hypocretin fibers of any brain area (Peyron et al.,
1998), baseline levels of hypocretin 1 in rats were observed to be significantly higher during the
dark (waking) period than during the light (sleeping) period (Kodama & Kimura, 2002).
Effects of exogenous hypocretins in sleep and arousal. Intracerebroventricular (i.c.v.)
administration of hypocretin 1 to rats resulted in a robust increase in wakefulness during the light
(sleep) phase of the circadian cycle (time spent awake was increased to 100% from a control
level of 39%). When administered during the dark (active) phase wakefulness was also
increased to 100% (from control levels of 69%), although this active-phase effect was marginally
nonsignificant (Espana, Plahn, & Berridge, 2002). In sleeping cats, microinjections of
hypocretin 1 into the laterodorsal tegmental nucleus (an area that participates in the induction of
sleep) produced a dose-dependent increase in the amount time spent awake (due to an increase in
the number of waking episodes) and a significant decrease in the amount of time spent asleep
(due to a decrease in the number of sleeping episodes) (Xi, Morales, & Chase, 2001).
Piper and colleagues (2000) reported that i.c.v. administration of hypocretin 1 to rats was
accompanied by an almost instantaneous decrease in either slow-wave or REM sleep, and
resulted in a dose-dependent increase in the amount of time spent awake as well as a marked
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decrease in both REM and NREM sleep (Piper, Upton, Smith, & Hunter, 2000). Additionally,
this effect could be reversed by prior i.c.v. infusion of the selective Hypocretin-R1 antagonist
SB-334867-A (Smith, Piper, Duxon, & Upton, 2003). Radio telemetry analysis further
indicated that i.c.v. infusion of hypocretin 1 in rats via a hydraulic minipump was able to reduce
the quantity of slow wave sleep by up to 120 minutes as compared to controls. Even the less
potent hypocretin 2 diminished slow wave sleep up to 30 minutes following post-infusion
(Vogel, Sanchez, & Jennum, 2002).
Although the exact mechanisms responsible for the relationship between the hypocretins
and sleep states are still unclear, evidence exists to support the theory that hypocretin 1 interrupts
sleep stages via actions in the locus coeruleus. One study showed both unilateral and bilateral
injections of hypocretin into the locus coeruleus sufficiently suppressed REM and slow wave
sleep; the injections actually resulted in a 70% increase in wakefulness (Bourgin, HuitronResendiz, Spier, Fabre, Morte, Criado, et al., 2000). As mentioned above, baseline levels of
hypocretin 1 are significantly higher in the locus coeruleus of nocturnal rats during the dark
(waking) period than during the light (sleeping) period. Furthermore, intravenous administration
of hypocretin 1 produced an increase in extracellular glutamate within the locus coeruleus
(Kodama & Kimura, 2002).
Hypocretins and sleep deprivation. Although many studies have examined (and
supported) a role for the hypocretins in sleep and arousal, few studies have investigated the
consequences of sleep deprivation on the hypocretin system and those that have yielded
inconsistent results. An in situ hybridization study in rats found no alteration in hypothalamic
PPH mRNA levels as a result of short-term (2 to 4 hours) sleep deprivation (Terao, Peyron,
Ding, Wurts, Edgar, Heller, et al., 2000). Dogs that were deprived of both food and sleep for 24
hours showed an increase in hypocretin 1 in cerebrospinal fluid; however, the authors of this
study attributed this effect to an increase in general activity levels associated with the sleep
deprivation paradigm (Wu, John, Maidment, Lam, & Siegel, 2002). In rats deprived of sleep for
periods between 5 and 19 hours prior to sacrifice, the proportion of Fos/hypocretin doublelabeled cells was increased compared to controls (Estabrooke et al., 2001). However, the use of
Fos immunocytochemistry in this type of experiment is not ideal for two reasons. First, Fos
protein remains in the cell for hours after a cell has become quiescent, resulting in poor temporal
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resolution. This is important in studies on a time scale like the one used by Estabrooke et al.
(2001). Second, and perhaps more importantly, Fos expression quickly desensitizes following
repeated or continuous stimulation (Hope, Kosofsky, Hyman, & Nestler, 1992). Thus, during
many hours of sleep deprivation, Fos expression may no longer be an accurate measure of
neuronal activity.
Role of hypocretins in learning and memory. As described above, sleep is thought to
play an important role in learning and memory (for review, see Siegel, 2001). Our studies, as
well as those of others, have indicated that sleep deprivation results in cognitive deficits. Given
these findings and the widespread distribution of hypocretin projections (including in areas
known to be involved in learning and memory) (see Figure 1 and Table 1), it is reasonable to ask
whether the hypocretins play a role in learning and memory per se. Recent electrophysiological
findings suggest that the hypocretins may modulate activity within the neural substrates of
learning and memory.
In mouse brainstem slices, application of either hypocretin 1 or hypocretin 2 had an
excitatory effect on mesopontine cholinergic neurons within the laterodorsal tegmental nucleus
(Burlet, Tyler, & Leonard, 2002). These cholinergic neurons provide a dense input to and have a
strong excitatory effect on ventral tegmental A10 dopaminergic neurons (Oakman, Faris, Kerr,
Cozzari, & Hartman, 1995; Oakman, Faris, Cozzari, & Hartman, 1999). Since release of
dopamine by A10 terminals in the nucleus accumbens plays a central role in motivational
processes (Wise & Rompre, 1989), excitation of this pathway by hypocretins has the potential to
influence any of a number of higher cognitive processes. Further support for a role of
hypocretins on the neural substrates of learning and memory comes from a study that employed
discrete intracerebral injections in rats of the neurotoxin saporin conjugated to hypocretin 2 to
produce a selective lesion of cells expressing hypocretin receptors (Gerashchenko, Salin-Pascual,
& Shiromani, 2001). Injections of hypocretin/saporin were made in the area of the medial
septum/diagonal band of Broca (MS/VDB), a site chosen because it is believed to be a source for
the origination of hippocampal theta rhythms (Bland & Vanderwolf, 1972; Whishaw & Nikkel,
1975) and because it receives hypocretinergic input from the hypothalamus (Figure 1, Table 1).
Theta rhythms are hypothesized to be involved with learning and memory and to assist with the
induction of long-term potentiation (Bland & Vanderwolf, 1972; Leutgeb & Mizumori, 1999).
Electroencephalographic (EEG) analysis showed that the loss of hypocretin-receptive neurons in
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the MS/VDB produced no changes in either slow wave or REM sleep. However, hippocampal
theta power was diminished by day-2 post-lesion and was completely abolished by day-12 postlesion; theta activity did not return even after 1 month’s time. These findings suggest that
hypocretin neurons could facilitate hippocampal theta activity (Gerashchenko et al., 2001), and
thus be involved directly with learning and memory. In contradiction to this hypothesis,
however, Aou et al., (2003) found that i.c.v. hypocretin 1 inhibited LTP in CA1 of hippocampal
slices in vitro (Aou, Li, Oomura, Shiraish, Sasaki, Imamura, et al., 2003).
Summary
In conclusion, investigations into the mechanisms of sleep deprivation-induced cognitive
deficits have the potential to be advanced with the discovery of two newly discovered peptides.
Termed the hypocretins, these peptides originate within the hypothalamus and send diffuse
projections throughout the brain. Several lines of evidence suggest a role for the hypocretins in
the neurobiology of sleep and waking, particularly in the initiation of arousal. There is
additional evidence linking hypocretin function to learning and memory processes; whether these
effects are specific for learning and memory or are the result of enhanced arousal remains to be
determined. Limited sleep deprivation studies have provided mixed information. However, they
do suggest that long-term, but not short-term, sleep deprivation may be correlated with an
increase in the activity of hypocretinergic neurons.
Hypothesis
The aim of this study was to investigate the effect of sleep deprivation on neuronal
hypocretinergic system(s) in rats. This was achieved by quantification of PPH mRNA levels
within the hypothalamus using in situ hybridization. Unlike classical neurotransmitters, peptide
transmitters are synthesized directly via gene transcription, the mRNA intermediaries of which
are relatively short-lived. Therefore, quantification of changes in mRNA levels is a reliable
indicator of peptidergic cell activity and neuropeptide release. The specific hypothesis to be
tested were as follows.

Hypothesis: Prepro-hypocretin mRNA levels will be modified in response to a 72hour total sleep deprivation period.
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Modification of PPH mRNA levels may occur in one of two directions. If
hypocretinergic neurons are capable of responding to behavioral conditions of forced
wakefulness, one might expect increased activity, and therefore increased PPH mRNA in an
attempt to maintain wakefulness in the presence of increased sleep drive. On the other hand, if
the activity of the hypocretinergic neurons themselves is indicative of the state of sleep/wake
drive, then one would expect PPH mRNA levels to decrease as sleep drive increases, i.e., during
the course of sleep deprivation. Given the current state of knowledge about the role of
hypocretins in sleep, it is impossible to predict which of these two outcomes is more likely to
occur.
This 72-hour time point, which has not previously been studied, was chosen due to the
extensive work in our laboratory that has shown a 72-hour sleep deprivation period is sufficient
to produce pronounced inhibition of LTP and hippocampal, but not amygdala, mediated learning
at this time point.
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Methods
Animals
Twenty-four adult male Sprague-Dawley rats (approximately 300 grams at beginning of
study) were singly housed upon arrival in hanging wire-mesh cages and randomly divided into
three treatment groups: control, sleep deprived and food deprived (described fully below).
Treatment groups, sample sizes, and time of sacrifice are summarized in Table 3. All animal
procedures were approved by the University of New Orleans Institutional Animal Care and Use
Committee and remained in compliance with standards set by the Public Health Service of the
National Institutes of Health.
All animals were sacrificed within the circadian time (or Zeitgeber time (ZT)) interval of
ZT6 and ZT7.
Animals were weighed daily between ZT6 and ZT7 in order to determine the amount of
weight gained or lost as a result of experimental manipulations.
Table 3. Time Schedule of Sleep and Food Deprivation
24-hours

48-hours

72-hours

Total

Sleep Deprived

-

-

8 rats

8

Food Deprived

-

8 rats

-

8

Home Cage Control

-

4 rats

4 rats

8
24

Behavioral Procedures
Home Cage Controls. Home cage control animals were individually housed in wiremesh hanging cages and had access to both food and water ad libitum. Due to the variation in
optimal treatment durations for food (48 hours) and sleep (72 hours) deprivation, the control
group was randomly divided into two equal subgroups, differing only in time of sacrifice. Fortyeight hours after the beginning of the experiment, four home cage control rats were sacrificed via
rapid decapitation using a guillotine. The remaining four home cage control rats were sacrificed
72-hours after the beginning of the experiment.
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Sleep Deprived Animals. Eight rats were deprived of all phases of sleep via the “platform
over water” method (Pujol, Mouret, Jouvet, & Glowinski, 1968). Sleep deprivation chambers
were constructed of Plexiglas® dimensionally measuring 38 x 46 x 24 cm in dimension (depth x
width x height). The sleep deprivation platform was 5 cm in diameter and was fixed in a
stationary manner in the middle of the chamber. The chamber was filled with water up to a point
1 cm below the surface of the platform. The nature of this paradigm is that, in order to avoid
falling into the water, the rat will be forced to maintain wakefulness to remain standing on the
platform. In the event the animal falls asleep it will lose its balance and fall into the water.
Falling into the water should cause the animal to reawaken and regain its position upon the
platform. Throughout sleep deprivation drinking water and food were supplied to the animal ad
libitum via a grate that fits across the top of the chamber. Rats were removed from the chamber
daily for the brief amount of time necessary to change the water inside the chamber. No animals
were observed as sleeping during this brief period.
Our extensive work with this apparatus has proven it to be a very safe and successful
method for maintaining wakefulness. Although excellent swimmers, rats find the water to be
aversive and have no difficulty climbing back onto the platform even after 72 hours of sleep
deprivation. This method of sleep deprivation has proven successful in our laboratory
(McDermott et al., 2003) as well as others (Pujol et al., 1968; Murison, Urson, Coover, Lien, &
Urson, 1982) for depriving animals of both REM and non-REM sleep. (Note that the small size
of the platform effectively prevents all phases of sleep, including slow wave sleep. Other
investigators have used larger platforms to induce selective REM sleep deprivation, which is not
the case in the present study. Using a 5-cm platform and animals of the size used here, we have
found that paradoxical sleep is almost completely abolished and slow wave sleep is reduced by
>50%; McDermott et al., 2003.)
Animals were placed in the sleep deprivation chambers at the beginning of the
experiment and remained in the chamber for a period of 72 hours. At the end of the 72-hour
period the animals were removed and immediately sacrificed, as described above.
Food Deprived Animals. Food-deprived animals were included in this study to serve as
positive controls. Previous studies have indicated that hypothalamic PPH mRNA levels increase
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as a result of fasting (Sakurai et al., 1998; Yamamoto, Ueta, Hara, Serino, Nomura, Shibuya, et
al., 2000; Nilaweera, Barrett, Mercer, & Morgan, 2003; Swart, Overon, & Houpt, 2001, XinYun, Bagnol, Burke, Akil, & Watson, 2000, Kurose, Ueta, Yamamoto, Serino, Ozaki, Saito, et
al., 2002). This manipulation was considered to be an important mechanism for the
interpretation and clarification of results, especially in the event that PPH levels are unaffected
by sleep deprivation.
At the beginning of the experiment, all rat chow was removed from the food hoppers of
the eight rats in this treatment condition. Water was still accessible ad libitum throughout the
experiment. Forty-eight hours after the food was removed all rats in this group were sacrificed,
as described above. This time point was chosen to correspond with the positive results achieved
by Sakurai et al. (1998) following a 48-hour time period.
Post-mortem Procedures
The dependent variable in this study is the amount of native PPH mRNA present in the
hypothalamic region of the brains of the rats described above. Determination of this variable
was achieved by quantification post mortem of PPH mRNA using in situ hybridization. Unlike
classical neurotransmitters, peptide transmitters are synthesized directly via gene transcription
and thus, have relatively short-lived mRNA intermediaries. Therefore, quantification of changes
in mRNA levels is a reliable indicator of peptidergic cell activity and neuropeptide release.
In situ hybridization is a histochemical technique that permits the visualization of
transcripts of a specific native mRNA within anatomically and morphologically preserved tissue
sections (Feldman, Meyer, & Quenzer, (eds), 1997, pg 32). This is achieved by means of
application to the post mortem tissue of a complementary nucleic acid ‘probe.’ The most
sensitive type of probe is a radiolabeled cRNA antisense probe that is several hundred bases
long. Using in vitro transcription, single-stranded RNA sequences are generated that have a
radioactive [35S] isotope attached to every uracil in the sequence. This ‘antisense’ probe binds
with very high affinity to the native sense mRNA by Watson-Crick pairing. (The term
‘hybridization’ refers to the formation of a double-stranded RNA hybrid consisting of a native
strand and a complementary artificial antisense strand.)
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Brain tissue preparation. Upon being sacrificed the animals’ brains were quickly
removed and immediately frozen in liquid isopentane (-18oC). They were stored at -80°C until
being sectioned on a cryostat in the coronal plane at a thickness of 20 µm. Sections through the
tuberal region of the hypothalamus were saved and thaw-mounted onto Vectabond®-treated
slides. Sections were then post-fixed in 4% paraformaldehyde in sterile 0.1 M phosphate buffer
for 15 minutes, followed by a 5-minute wash in 0.05 M phosphate buffer and 1-minute wash in
sterile deionized distilled water. Following post-fixing slides were stored at -80°C until
hybridization.
Generation of antisense prepro-hypocretin probe. The antisense probe for PPH mRNA
consisted of a single strand of 427 ribonucleic acid bases complementary to the region between
bases 61 and 489 of the native ‘sense’ mRNA transcript. Double-stranded (ds) PPH DNA was
amplified from rat brain cDNA via polymerase chain reaction (PCR) using the following
primers:
Upstream:

5’-CGG ATT ACC TCT CCC TGA GCT-3’

Downstream: 5’-CAC CGG GTT CAG ACT CTG GAT C-3’
Non-underlined bases correspond to PPH sequences. The four 5’-most bases of the
downstream primer (underlined) are part of a recognition sequence (5’-CCC TTC ACC-3’) for
the viral enzyme topoisomerase (see below) which therefore ensures cloning of the PPH-specific
region into the plasmid in the correct orientation (in this case antisense) and at the correct locus
(just downstream from the RNA polymerase promoter).
A sample of the resulting PCR product was then subjected to electrophoresis to determine
the size, quality and approximate quantity of the product. Once the product was identified as
being the correct size (Fig. 2) it was purified using Qiagen® spin columns. The PCR product was
then inserted into the vector pcDNA3.1D/TOPO® by means of a 5-minute topoisomerasemediated reaction at room temperature. The insert-containing plasmid was then used to
transform bacteria (TOP10® competent E. coli cells) by heat-shock (20 min. on ice followed by
30 sec. at 42oC). After heat shock the cells were immediately placed back on ice. SOC medium
was then added to the cells and the cells were incubated for one hour at 37ºC and swirled at 200
rpm. Subsequent to this incubation period the cells were spread thinly onto a bacteria culture
plate containing Luria Broth with ampicillin (LBA). These cells were allowed to incubate on the
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plates overnight at 37ºC thereby generating clonal colonies. The following day the number of
bacterial colonies per plate was quantified and six independent bacterial colonies (those that had
no contact with neighboring colonies) were selected from the plate. These colonies were placed
into a culture tube containing 3ml of LBA to incubate overnight at 37ºC, 300 rpm. After the
incubation period the test tube cultures were subjected to a miniprep procedure to purify the
plasmid from the bacteria.
A sample of the purified plasmid minipreps was then digested with the restriction
enzymes HindIII and XbaI. These restriction enzymes were chosen because their target
sequences had been strategically engineered into the vector such that they were adjacent to the
ends of the transfected PCR product and would therefore excise the target product. The digestion
was performed at 37ºC for four hours and the end product (linear dsDNA corresponding to PPH)
was visualized via gel electrophoresis. A digested sample was considered successful when the
gel visualization revealed two distinctly different sized bands representing the insert (~427 bases
long) and the vector (~5.5 kb).
A sample of the purified insert was subjected to full sequencing (Tulane DNA
Sequencing Facility) to determine that the insert was of the correct sequence and had been
transfected in the correct orientation. Correctly transfected miniprep samples were then
linearized by digesting with the XbaI restriction enzyme for 4 hours at 37ºC. A 1µl sample of
the digested product was visualized via gel electrophoresis to determine the accuracy of the
digestion. The remaining product was purified using Qiagen® spin columns.
The final product (linearized dsDNA corresponding to PPH under the control of the T7
RNA polymerase promoter) was then used as a template for the transcription of single-stranded
(ss) RNA in the presence of T7 polymerase, unlabeled ATP, GTP, CTP and radioactively labeled
[35S]UTP. Thus, every uracil in each probe (~100) was radioactive. Because of the directional
insertion into the plasmid the resulting product was ssRNA that was perfectly complementary to
native PPH mRNA—it was, thus, an antisense probe. For control purposes, ssRNA sense probe
was generated in the same manner except that the CACC topoisomerase consensus sequence was
added to the 5’-most base of the upstream PPH-specific primer sequence (see above) in the
initial PCR reaction.
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Antisense probes were expected to bind to native mRNA, thereby generating a detectable
signal, whereas sense probes were expected not to bind to any nucleic acid sequence in the brain
(due to the uniqueness of a 427-base sequence; P = 1/4427), and thereby provided a negative
control.
Figure 2: Gel electrophoresis visualization of PPH Antisense and
Sense Riboprobe. Probes are approximately 430 nucleotides in length
indicating successful PCR extractions of PPH Antisense and Sense
strands.

Hybridization. At the time of hybridization the slides were removed from the freezer and
allowed to warm to room temperature before being subjected to a series of acetylations and
dehydrations. These washes served to facilitate the adherence of the probe to the mRNA as well
as minimize non-specific probe binding. The slides were then saturated with a hybridization
solution that contained either radiolabeled antisense or sense PPH probe. Slides were then
coverslipped and incubated for a period of between 12 and 16 hours, after which time they were
subjected to a series of high-stringency washes. These washes served to remove all nonspecifically-bound probe, thereby generating a very high signal:noise ratio.
Autoradiography and quantification. Experimental slides and calibration slides
(containing standards labeled with known quantities of 14C) were exposed to photographic film
(BioMax, MS-1; Kodak™) in the dark and enclosed within a light-tight film cassette. The film
was exposed for approximately 20 days and was developed according to standard photographic
procedures (5 minutes in developer, 30 seconds in a water rinse and 5 minutes in a fixative.)
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For quantification, exposed film was placed on a light box. Close-up images were
captured via a CCD video camera and transmitted to a computer-assisted image analyzer
equipped with MCID™ software. A calibration curve was established for each piece of film by
quantifying the relative optical densities of each 14C standard and entering the known amount of
radioactive emissions for each.
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Results
Weight Loss
A repeated measures analysis revealed a significant between-group difference for weight
loss (F (2,14)= 14.186, p<.01) (Fig. 3). Scheffé post hoc testing revealed that food-deprived
animals lost significantly more weight then home cage animals (p<.01). Sleep deprived animals
also suffered from significant weight loss compared to control animals (p= .02), however weight
loss in sleep deprived animals was not as dramatic as that seen in food deprived animals (p=.07).

Average Weight in Grams:
Control, Sleep Deprived, Food Deprived
300

Average Weight in Grams

250

*
*

200

150

100

50

Sleep Deprived
Home Cage
Food Deprived

0
0

24

48

72

Hours
Figure 3: Average weight in grams. Significant between-group effect: Sleep and Food
Deprived animals lost significantly more weight then control animals (p< 0.05, *).
A Scheffe post-hoc test revealed total weight loss in Sleep Deprived animals was
marginally non-significant when compared to Food deprived animals (p=.07).
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Hypocretin Antisense Binding
The extremely restricted extent of Hypocretin-positive neurons combined with variations
in anterior/posterior (A/P) levels of slides exposed to PPH antisense riboprobe precluded analysis
of all twenty-three slides. Sixteen slides (consisting of five home cage controls, four sleepdeprived animals and 6 food-deprived animals) exhibited quantifiable signals. Sections on these
slides corresponded to Plates 31-32 in the widely-used rat brain atlas of Paxinos and Watson
(1998) (Fig. 4). For each brain section, relative optical densities were quantified for each of 6
subregions within a 2 x 3 matrix of 500 x 500-µm squares, as described in Methods. Subregions
were classified as dorsal or ventral (2 within-subjects levels) and as medial, middle, or lateral (3
within-subjects level in the mediolateral dimension).

Figure 4: Illustration of preprohypocretin in situ hybridization
superimposed over coronal brain section outline (Paxinos &
Watson, 1988).
In situ hybridizations (and the molecular biology protocols leading up to them) were
highly successful as judged by the pronounced appearance of signal and low background within
the hypothalamic region where PPH-positive neurons have been shown to exist. A three-factor
ANOVA (Group x Dorsoventral x Mediolateral) yielded highly significant subregional
differences in the amount of PPH signal detected (Fig. 5). There was a significant mediolateral
(ML) effect (F (2,24)= 11.107, p<0.001), a significant dorsoventral (DV) effect (F (1,12)= 5.741,
p=0.034), and a significant interaction between the two (DV x ML: F (2,24)= 9.779, p<0.001).
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Subregional PPH Quantification
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Figure 5: Dorsal (black) vs. Ventral (gray) bars illustrate subregional differences in relative
optical density of PPH as measured via in situ hybridization. At the Dorsal level post hoc
Scheffe tests revealed that the Middle subregion expressed significantly higher levels of
PPH then either the Medial or Lateral subregions (p< 0.05, *). At the Ventral level the
Medial subregion expressed a significantly higher level of PPH then the Lateral subregion
(p< 0.05, *).

Subsequent Tests of Simple Effects showed that the ML effect was significant at both the
dorsal (p<0.002) and ventral (p<0.03) levels. Post hoc Scheffé tests showed that at the dorsal
level, PPH signal in the middle region was significantly higher (p<0.05) than either the medial or
lateral regions, which did not differ significantly from each other. At the ventral level, PPH
signal in the medial region was significantly higher (p<0.05) than that in the lateral region
(p<0.05), whereas the middle region did not differ significantly from either the medial or the
lateral. The DV effect was not significant at the middle ML level, was highly significant at the
medial level (p<0.001; dorsal > ventral) and marginally nonsignificant at the lateral level
(p=0.053).
The between-subjects factor Group (Home Cage vs. Sleep-Deprived vs. Food-Deprived)
was not significant either alone or in interaction with any of the other factors (F < 1 in all cases)
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(Fig. 6). Sections were also analyzed to determine whether the area of PPH mRNA signal
differed significantly between groups. However, a oneway ANOVA revealed no effect of group
(F(2,11)= .12, p= .884) on average mRNA area.

Average Total Optical Densities Collapsed
Across Hemispheres

Relative Optical Density

0.4

0.3

0.2

0.1

0.0

Home Cage
Sleep Deprived
Food Deprived
Control
Figure 6: Average relative densities collapsed across hemispheres. Sections analyzed to determine
whether PPH mRNA density differed significantly between groups. No significant between-group
differences existed.

Hypocretin Sense Binding
When matched to antisense exposed slides for A/P level, sections exposed to the sense
riboprobe exhibited no PPH mRNA binding (p<.01). This finding provides confidence that the
antisense riboprobe was specific for PPH mRNA and not an artifact.
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Discussion
The target region of the gene encoding PPH was successfully amplified from rat cDNA,
cloned into a plasmid vector and transformed into bacteria for amplification and generation of
sense and antisense riboprobes for use in in situ hybridization. The in situ hybridization with
antisense probe was also successful, generating clear images of PPH signal against a low
background of noise. Hybridization with a sense probe yielded only background images with no
signal.
Quantitative analysis of PPH mRNA for the first time revealed anatomical differences in
the amount of native PPH among different subregions of the tuberal hypothalamus, regardless of
treatment group. In general there were decreasing medial-to-lateral and dorsal-ventral gradients
indicating that discrete subnuclei within the tuberal hypothalamus probably play distinct roles in
functions mediated by the hypocretin peptides. Future studies should take into account these
regional differences.
With respect to treatment, no significant changes in the amount of PPH mRNA signal
were detected, despite evidence indicating a role for hypothalamic PPH in both sleep and
feeding. In the present study, hypothalamic PPH levels following a chronic (72-hour) sleep
deprivation period were no different from those of home cage controls.

Additionally,

hypothalamic PPH mRNA levels were not elevated following a 48-hour total food deprivation
period. This finding is in opposition to previous studies during which PPH mRNA levels were
elevated following a 48-hour fasting period (Sakurai et al., 1998; Yamamoto et al., 2000;
Nilaweera et al., 2003; Swart et al., 2001, Xin-Yun et al., 2000).
It was hypothesized that sleep deprivation might induce changes in hypothalamic PPH
levels in one of two directions. Observed increases would lead to the conclusion that hypocretin
levels reflected behavioral demands placed on an animal; thus, forced wakefulness would elevate
the wakefulness-promoting Hypocretin peptides. Alternatively, if decreases in PPH levels had
been observed, it may have been concluded that hypocretins serve as effector mechanisms of a
putative sleep/wake ‘homeostat,’ responding to the level of sleep/wake drive. Assuming that
sleep and feeding drive systems operate similarly, previous research on food deprivation had
suggested the latter interpretation was not the case, suggesting indirect support for the first
hypothesis. Further support for the former expectation was provided by the results of double
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labeling of Fos and hypocretin 1 in sleep deprivation experiments (which may be problematic for
reasons described in the Introduction). Nonetheless, no change in either direction was detected
despite sufficient statistical power and despite the fact that significant regional differences were
clearly detectable.
Failure of the food deprived group serving as a positive control to register a significant
difference in PPH mRNA levels as compared to controls, or for a 72-hour sleep deprivation
period to have an impact on hypothalamic PPH levels, is not necessarily indicative of poor
experimental methodology, with regard to in situ hybridization.

The unusually restrictive

anatomical anterior/posterior extent of the hypothalamic neurons gave rise to an unexpected
result; in each animal only a limited number of sections revealed PPH positive cells. Despite
this, sections that did provide a signal did so with an appropriate signal-to-noise ratio.
Furthermore, the sections revealing a signal were bordered immediately anterior and
immediately posterior by sections completely void of any PPH signal (registering only a
background signal). The specificity of this signal, namely the fact that no PPH positive cells
were observed in sections very similar in anatomical level to PPH positive sections, supports the
present experimental methods.

In fact, the lack of signal observed in these anatomically

surrounding sections was analogous to signal observed in anatomically matched sections
hybridized with a sense (control) riboprobe. This strengthens the likelihood the obtained results
are not due to methodological error.
It is therefore necessary to investigate the origin of the present findings. Potential
explanations fall under four domains,
1)

The inability to discriminate between hypothalamic neuronal subpopulations
via in situ hybridization

2)

Hypocretin fluctuations in accordance with the circadian cycle

3)

The role of hypocretins in locomotive behavior

4)

Inextricably confounded variables.

Inability to discriminate hypothalamic neuronal subpopulations via in situ hybridization
Our study revealed no difference between a sleep deprived group and a control group in
hypothalamic PPH levels following a 72-hour sleep deprivation period at ZT6. As this study is
the first to investigate PPH levels via in situ hybridization following chronic sleep and food
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deprivation, the discrepancy between the present and previous results may signify that sleep or
food deprivation-induced changes on the hypocretin system actually reveal a peptidergic effect
of these manipulations and not a mRNA effect. In other words, it is possible that hypocretin
release may be increased or decreased due to a change in homeostatic mechanisms (e.g. increases
in proteolytic degradation of mature peptides or propeptides), yet PPH levels are so
homeostatically entrained they are still produced at a constant level.
It is also notable that a variety of neuronal subpopulations exist within the hypothalamus
(Swanson & Sawchenko, 1980). While an in situ hybridization technique is adequate for the
visualization and quantification of neuronal cell bodies that are producing mRNA (in this case,
PPH), this technique does not discriminate between the possible distinct subpopulations of PPHpositive neurons. For example, group differences may exist within the population of
hypothalamic neurons that co-express PPH and norepinephrine, a transmitter commonly
associated with sleeping behaviors (Espana & Scammell, 2004). Such an analysis is feasible via
a double-labeled in situ hybridization technique; however this was beyond the scope of the initial
investigation. Thus, it remains possible that chronic sleep and chronic food deprivation may
have produced between-group differences in PPH levels within a subpopulation of PPH cells that
were not distinguished in the present study.

Hypocretin fluctuations in accordance with the circadian cycle
Hypocretins have been observed to vary in a circadian manner. Taheri et al. (2000)
reported that hypothalamic PPH levels rise steadily prior to the beginning of the dark cycle and
fall just prior to the beginning of the light cycle (Taheri et al., 2000). However, Martinez et al.
(2002) refuted the likelihood that hypocretins respond merely to photic stimuli. Estabrooke and
colleagues (2001) observed an increase in Fos-positive hypocretin cells during the dark (but not
the light) phase of the circadian cycle, and this elevation was also observed during the subjective
night cycle of animals maintained on a 24-hour dark cycle schedule (Estabrooke et al., 2001).
In a study published after the present research was undertaken, Pederazzoli and
colleagues measured hypocretin-1 cerebrospinal fluid levels at a 6-hour and a 96-hour sleep
deprivation time point, as well as post-rebound sleep (Pederazzoli, Almeida, Martins, Machado,
Ling, Nishino, et al., 2004). At each of these temporal points researchers sampled CSF levels
from rats for two different circadian times ZT0 and ZT8. At the ZT0 measurement point no
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significant group differences in CSF hypocretin-1 levels were observed between either the 6hour sleep deprivation period, the 96-hour sleep deprivation period or the subsequent sleep
rebound period (Pederazzoli et al., 2004). However, at ZT8 96-hours (but not 6 hours) of sleep
deprivation led to a significant increase in CSF hypocretin-1 levels. Furthermore, hypocretin-1
levels were significantly reduced during rebound sleep (Pederazzoli et al., 2004). The failure of
sleep deprivation to alter hypocretin CSF levels at ZT0 but create dramatic differences at ZT8
led Pederazzoli and colleagues to suggest the presence of a hypocretin “ceiling effect”. It is
possible that hypocretin levels at ZT0 may already be maximal and unable to increase further
(Pederazzoli et al., 2004). More closely related to the present study is the finding that PPH
mRNA levels were not reduced below the maximal level at ZT6 (Taheri et al., 2000), the time at
which the present study was conducted. [It is important to report that evidence exists to indicate
that CSF hypocretin levels are representative of hypothalamic hypocretin levels (Gerashchenko,
Murillo-Rodriguez, Lin, Xu, Hallet, Nishino, et al., 2003)].
A similar finding regarding 24-hour food deprivation further substantiates this
hypothesis. Fujiki and colleagues (2001) reported that hypocretin CSF levels were significantly
increased following 24-hour total food deprivation at the ZT8 circadian time point, however no
differences existed between the fasting group and the control group at ZT0 (Fujiki, Yoshida,
Ripley, Honda, Mignot & Nishino, 2001). Hypocretin CSF levels failed to increase at ZT0 even
after 72-hours of food deprivation, leading these researchers to hypothesize that hypocretin
levels may reach a physiological maximum following extended stress and that this maximal level
is attained independent of the circadian time point (Fujiki et al., 2001).
It remains possible that chronic sleep deprivation and chronic food deprivation did induce
changes in PPH mRNA, yet differences were obscured in the present study by a ceiling effect
resulting from the choice of ZT6 as the time of measurement

The role of hypocretins in locomotive behavior
Another behavior thought to be mediated by hypocretins, locomotion, may account for
discrepancies between current and previous results. While hypocretins have been shown to have
some involvement in such homeostatic mechanisms as sleeping and eating, evidence also exists
to support a role for hypocretin in locomotive behavior. For example, Martins and colleagues
(2004) found that hypocretin CSF levels measured at ZT0 were significantly decreased following
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long-term immobilization, yet hypocretin CSF levels were increased following short-term forced
swimming at ZT8. These results are striking in that they directly contrast with the consistent
finding that hypocretin levels are elevated (and perhaps saturated) at ZT0 and decline by ZT8
(Pederazzoli et al., 2004, Fujiki et al., 2001). These researchers also reported that hypocretin
CSF levels did not change in response a short-term immobilization period, in response to a total
sleep deprivation period or in response to cold exposure, at either ZT0 or ZT8 (Martins,
D’Almeida, Pedrazzoli, Lin, Mignot, & Tufik, 2004).
Further support for a role of hypocretin in locomotion comes from Kiwaki et al. (2004),
who employed a cannula to inject 1 nmol of hypocretin 1 into the paraventricular nucleus of the
hypothalamus in freely moving rats. These researchers reported that, irrespective of ZT time,
1nmol of hypocretin 1 resulted in a significant increase in spontaneous activity (as measured by
infrared beam break count) that lasted up to two hours post injection. This response increased in
a dose response fashion up to an injection level of 2nmol. This finding was corroborated by the
fact that oxygen consumption (as measured by indirect calorimetry) increased at a rate
comparable to spontaneous activity.

Furthermore, injection of SB-334867-A (a hypocretin

receptor 1 antagonist) attenuated this effect.

Feeding behavior in response to hypocretin

administration was also recorded and was only observed to increase when hypocretin 1 was
administered early in the light phase (Kiwaki, Kotz, Wang, Lanningham-Foster, & Levine,
2003). These authors concluded that hypocretin 1 in the paraventricular nucleus could act to
increase non-feeding associated physical activity (Kiwaki et al., 2003).
Another group of researchers utilized in vivo microdialysis in freely moving cats to
measure hypothalamic hypocretin peptide concentration. Dialysate hypocretin peptide levels
were elevated during both the active waking and REM-sleep periods as compared to levels
recorded during slow wave sleep. These results led researchers to purport a role for hypocretins
in the central programming of motor activity (Kiyashchenko et al., 2002). Additionally, Wu et
al. (2002) reported that, in Doberman pinschers, hypocretin CSF levels remained unchanged
following a 48-hour food deprivation period, whereas hypocretin levels were elevated up to 70%
over baseline following a 24-hour sleep deprivation period. However, the magnitude of the
hypocretin CSF level elevation during the sleep deprivation (which was accomplished by
consistently walking the dogs) correlated positively with the level of motor activity the animal
engaged in during the deprivation period. Moreover, a 2-hour period of exercise in the same test
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subjects elevated hypocretin-1 CSF to a level of 57% over baseline, the extent of the increase
being positively correlated with the level of motor activity (Wu et al., 2002).
The role of hypocretins in locomotive behavior is further demonstrated by the fact that
microinjection of hypocretin-1 into the locus coeruleus (an area with dense hypocretinergic
innervations and whose descending projections are partially involved with the facilitation of
muscle tone regulation) of decerebate rats facilitated muscle tone in either the ipsi- or bilateral
hindlimb muscle. Microinjection of either hypocretin 1 or 2 into the pontine inhibitory area,
(another area with moderate hypocretinergic innervations that participates in the suppression of
muscle tone during REM sleep), inhibited muscle facilitation. Despite this, direct application of
hypocretin 1 or 2 to muscles did not result in any significant facilitation or inhibition of muscle
tone. This led to the conclusion that hypocretin peptides influence muscle tone in a centrally
mediated fashion (Kiyashchenko et al., 2001). Furthermore, microinjection of hypocretin-1 into
medullary gigantocellular reticular alpha (GiA) and ventral (GiV) nuclei parts, both of which
receive hypocretinergic innervations and participate in the induction of locomotion and muscle
tone facilitation in decerebate animals, also resulted in an increase in muscle tone facilitation.
This further strengthens the hypothesis that hypocretins actively mediate muscle facilitation and
inhibition (Mileykovskiy, Kiyashchenko, & Siegel, 2002).

Together this research provides

strong evidence linking the hypocretins with locomotive behavior.
In the present study sleep deprivation greatly reduced the amount of locomotion that an
animal could exhibit. Therefore, immobilization-induced decreases in PPH could have been
offset by sleep deprivation-induced increases resulting in an apparent effect of zero.

The hypocretin influence and inextricably confounded variables
Previous efforts to investigate the role of the hypocretins in sleeping and feeding
behavior have yielded inconsistent results.

Experiments investigating the effect of sleep

deprivation on hypocretin output have utilized multiple methodologies and reported either no
effect on PPH levels via in situ hybridization (Terao et al., 2000), a nominal effect via hypocretin
CSF levels in active Doberman pinschers (Wu et al., 2002) or a large increase inferred from Fos
immunohistochemistry (Estabrooke et al., 2001). While experiments that involved hypocretin 1
i.c.v. microinjections (Piper et al., 2000; Espana et al., 2002, Vogel et al., 2002) all reported a
significant increase in time spent awake and a significant decrease in time spent in REM or slow
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wave sleep in response to the presence of hypocretin, none of these researchers failed to assess
locomotive behavior as a potential factor affecting the outcome of the experiment. Due to the
relationship between microinjections of hypocretin and muscle tone facilitation (Kiyashchenko et
al., 2001, Mileykovskiy et al., 2002) as well as centrally mediated muscle facilitation or
inhibition (Martins et al., 2004, Kiwaki et al., 2004, Kiyashchenko et al., 2002) it remains
unclear whether the increase in time spent awake following i.c.v. injection of Hypocretin 1 is
more attributable to an increase in locomotive behavior rather then more general increase in
arousal.
The failure of experiments to continually yield consistent results regarding the role of the
hypocretin peptides may be attributable to the failure of these studies to control for level of
locomotion as a mediating factor. It may also be the case that these variables are not completely
discernable. For example, while the sleep deprivation paradigm utilized by the present study
successfully denies the animals of REM and nonREM sleep, it also constitutes a long-term
immobilization paradigm. Long-term immobilization has been previously reported by Martins
and colleagues to significantly reduce hypocretin CSF levels (Martins et al., 2004).
Additionally, although evidence indicates a role for hypocretins in the circadian cycle, it is
unknown the extent to which this cycle varies in accordance with locomotive manifestations. In
fact evidence suggests that, with respect to stimulation of hypocretin levels, locomotion is
perhaps the only variable that does not vary in respect to circadian rhythm (Martins et al., 2004).
It is therefore possible that the role hypocretin peptides play in such homeostatic drives as
sleeping and feeding behavior will always result in an inherent measurement confound. For
example, evidence exists that while rats are being deprived of food they may not achieve
adequate amounts of sleep. EEG and EMG recordings of rats during an 80-hour total food
deprivation period revealed that food deprivation led to a shortening of sleep episodes
(specifically shortening the amount of time spent in REM and slow wave sleep stages), causing
a change in the light-dark distribution of the sleep states (Borbēly, 1977).

The present

experiment revealed that animals sleep deprived for 72-hours lost a significant amount of weight
as compared to control animals.
Based on the findings of the present study as well as previous experimental
manipulations, it is hypothesized that the hypocretin peptides are so heavily ingrained within
other homeostatic systems that it may not be possible to define a clearly established role for these
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peptides.

This is due to the inherent tendency of their constituent functions to create

measurement confounds.
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